US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.340
  • +0.013+3.99%
15min DelayClose Mar 28 15:36 ET
1.65MMarket Cap-0.01P/E (TTM)

Panbela Therapeutics Key Stats

Panbela Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 13, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Aug 13, 20242024/Q20.000 / 0.000--
May 15, 20242024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
Nov 9, 20232023/Q30.000 / 0.000--
Aug 10, 20232023/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Panbela Therapeutics Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.